Christopher Miller (CRD 4044818) has a customer dispute on BrokerCheck that settled on October 7, 2026 for $50,901. The disclosure lists Emerson Equity as the firm.
In a recent article from Forbes, the worst performing biotech stocks from 2013 were listed. Of the companies that posted negative results, the worst damage came to those that presented bad clinical data or had run-ins with the U.S. Food and Drug Administration.
The Worst-Performing Biotech Stocks of 2013
CLSN Celsion Corporation 52.9 -89.4
ASTM Aastrom Biosciences, Inc. 14.1 -87.2
DCTH Delcath Systems, Inc. 32.2 -79.3
CVM CEL-SCI Corporation 28.9 -78.1
AVEO AVEO Pharmaceuticals, Inc. 94.9 -77.3
AMRN Amarin Corporation Plc Sponsored ADR 340.1 -75.6
ENZN Enzon Pharmaceuticals, Inc. 51.1 -73.8
ZLCS Zalicus Inc. 29.0 -71.5
ECTE Echo Therapeutics, Inc. 33.1 -69.8
SPHS Sophiris Bio Inc. 59.8 -68.9
PBMD Prima Biomed Ltd Sponsored ADR 45.1 -68.6
PTX Pernix Therapeutics Holdings, Inc. 93.7 -67.5
OXBT Oxygen Biotherapeutics, Inc. 47.8 -65.1
ARIA ARIAD Pharmaceuticals, Inc. 1,266.2 -64.4
GTXI GTx, Inc. 104.3 -60.7
INFI Infinity Pharmaceuticals, Inc. 664.1 -60.5
ONCY Oncolytics Biotech Inc. 131.4 -60.5
VICL Vical Incorporated 102.4 -59.5
BAXS Baxano Surgical, Inc. 45.6 -59.3
ACHN Achillion Pharmaceuticals, Inc. 320.8 -58.6
BTK AMEX Biotechnology Index 0.0 50.6
If your broker/financial advisor recommend any of these biotechs and did lost more than $50,000, call for a free consultation with an attorney on how to potentially recover your investment losses: 888-760-6552. Soreide Law Group represents clients nationwide in arbitrations before FINRA.
Christopher Miller (CRD 4044818) has a customer dispute on BrokerCheck that settled on October 7, 2026 for $50,901. The disclosure lists Emerson Equity as the firm.
A customer dispute that settled for $80,000 on July 16, 2026 is the newest entry on the BrokerCheck report of Stephen Kerutis (CRD 2345517). The clients in that matter alleged unsuitable recommendations, and Truist Investment Services is the firm on the disclosure.
Steven Graham (CRD 1977736) denies the allegations in a pending customer claim filed on August 11, 2026. The disclosure names Western International Securities as the firm, and the claim involves corporate bonds. No arbitrator has ruled on it. His BrokerCheck report also lists a settled bond dispute and a federal court matter from earlier years.
Phone:
Fax: 1-954-760-6553
Email: [email protected]